Researchers have found that according to existing evidence from randomized controlled trials, routinely screening large populations of men for prostate cancer is not recommended. Their report appears in today's issue of the BMJ (British Medical Journal). Another study published today in the same medical journal, though, recommends a single test at 60 years of age to identify males most like to develop and possibly die from prostate cancer. These patients could then be monitored, while others would be exempt from further tests...
More...
More...